Biogen Inc (NASDAQ:BIIB)

404.28
Delayed Data
As of Jul 02
 -1.13 / -0.28%
Today’s Change
290.85
Today|||52-Week Range
480.18
+19.10%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Biogen have a median target of 480.00, with a high estimate of 525.00 and a low estimate of 422.00. The median estimate represents a +18.73% increase from the last price of 404.28.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Biogen. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$4.06
Sales
$2.7B
Reporting Date
Jul 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.25%
 
 
 
 
 
 
Growthannually 20.74%
 
 
 
 
 
 

Sales

Growthquarterly 5.83%
 
 
 
 
 
 
Growthannually 13.25%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account